News | October 13, 2021
PCI Pharma Services acquires LSNE for its CDMO business
Transformational partnership establishes PCI as a CDMO and broadens capabilities across drug product lifecycle
Transformational partnership establishes PCI as a CDMO and broadens capabilities across drug product lifecycle
The company plans to raise US $ 15 million
Since its inception, the company has either acquired or taken a majority stake in five companies
The transaction is anticipated to close in the first quarter of 2022
The company claims to be a market leader in core orthopaedic and gynaecology segments like bone and joint disorders, pain management and, pregnancy and women’s nutrition
Ectosense’s NightOwl is a leading cloud-connected home sleep apnea test
Torrent is one of India's fastest-growing pharma majors
The acquisition complements and strengthens Merck’s cardiovascular pipeline
The issue will consist of the issuance of fresh equity shares worth up to Rs 331.60 crore and an offer for sale (OFS) of Rs 500 crore by promoters and existing shareholders
The global wellness market is valued at more than US $ 1.5 trillion, with annual growth of 5-10 per cent
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
